528 related articles for article (PubMed ID: 10336572)
21. Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators.
Knight CJ; Fox KM
Am J Cardiol; 1998 Jan; 81(2):133-6. PubMed ID: 9591893
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina.
Chugh SK; Digpal K; Hutchinson T; McDonald CJ; Miller AJ; Lahiri A
J Cardiovasc Pharmacol; 2001 Sep; 38(3):356-64. PubMed ID: 11486240
[TBL] [Abstract][Full Text] [Related]
23. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.
Pehrsson SK; Ringqvist I; Ekdahl S; Karlson BW; Ulvenstam G; Persson S
Clin Cardiol; 2000 Oct; 23(10):763-70. PubMed ID: 11061055
[TBL] [Abstract][Full Text] [Related]
24. Mibefradil: a new class of calcium-channel antagonists.
Billups SJ; Carter BL
Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
[TBL] [Abstract][Full Text] [Related]
25. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
[TBL] [Abstract][Full Text] [Related]
26. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
Tzivoni D; Kadr H; Braat S; Rutsch W; Ramires JA; Kobrin I
Circulation; 1997 Oct; 96(8):2557-64. PubMed ID: 9355894
[TBL] [Abstract][Full Text] [Related]
28. Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist.
Kobrin I; Charlon V; Lindberg E; Pordy R
Am J Cardiol; 1997 Aug; 80(4B):40C-46C. PubMed ID: 9286853
[TBL] [Abstract][Full Text] [Related]
29. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
Brogden RN; Markham A
Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
[TBL] [Abstract][Full Text] [Related]
30. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.
Dunselman PH; van Kempen LH; Bouwens LH; Holwerda KJ; Herweijer AH; Bernink PJ
Am J Cardiol; 1998 Jan; 81(2):128-32. PubMed ID: 9591892
[TBL] [Abstract][Full Text] [Related]
31. Comparative antihypertensive effectiveness of once-daily mibefradil and diltiazem CD. Mibefradil Hypertension Study Group.
Bittar N
Clin Ther; 1997; 19(5):954-62. PubMed ID: 9385483
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
Leon MB; Rosing DR; Bonow RO; Epstein SE
Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518
[TBL] [Abstract][Full Text] [Related]
33. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of once-daily amlodipine versus twice-daily diltiazem controlled release (CR) in the treatment of stable angina pectoris. Amlodipine Study Group.
van Kesteren HA; Withagen AJ
Cardiovasc Drugs Ther; 1998 Oct; 12 Suppl 3():233-7. PubMed ID: 9800052
[TBL] [Abstract][Full Text] [Related]
35. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy and tolerability of two long-acting calcium antagonists, mibefradil and amlodipine, in essential hypertension. Mibefradil Hypertension Study Group.
Karch FE; Pordy R; Benz JR; Carr A; Lunde NM; Marbury T; Tarro JN
Clin Ther; 1997; 19(6):1368-78. PubMed ID: 9444446
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of mibefradil in subgroups of patients with chronic stable angina pectoris.
Charlon V; Kobrin I
Int J Clin Pract; 1998 Jun; 52(4):257-64. PubMed ID: 9744152
[TBL] [Abstract][Full Text] [Related]
38. [Effects of long-acting calcium antagonists--amlodipine and diltiazem in patients with stable angina of effort: comparative randomized controlled trial].
Martsevich SIu; Sementsov DP; Kutishenko NP; Alimova EV
Ter Arkh; 2001; 73(9):42-6. PubMed ID: 11642080
[TBL] [Abstract][Full Text] [Related]
39. Improved efficacy and safety of controlled-release diltiazem compared to nifedipine may be related to its negative chronotropic effect.
Basu SK; Kinsey CD; Miller AJ; Lahiri A
Am J Ther; 2000 Jan; 7(1):17-22. PubMed ID: 11319569
[TBL] [Abstract][Full Text] [Related]
40. A randomised, double-blind trial comparing mibefradil and amlodipine: two long-acting calcium antagonists with similar efficacy but different tolerability profiles. Mibefradil International Study Group.
Viskoper RJ; Bernink PJ; Schelling A; Ribeiro AB; Kantola IM; Wilkins MR; Kobrin I
J Hum Hypertens; 1997 Jun; 11(6):387-93. PubMed ID: 9249234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
